| Interleukin-8 as a macrophage-derived mediator of angiogenesis AE Koch, PJ Polverini, SL Kunkel, LA Harlow, LA DiPietro, VM Elner, ... Science 258 (5089), 1798-1801, 1992 | 2755 | 1992 |
| Biological action of leptin as an angiogenic factor MR Sierra-Honigmann, AK Nath, C Murakami, G Garcıa-Cardena, ... Science 281 (5383), 1683-1686, 1998 | 1928 | 1998 |
| The functional role of the ELR motif in CXC chemokine-mediated angiogenesis RM Strieter, PJ Polverini, SL Kunkel, DA Arenberg, MD Burdick, J Kasper, ... Journal of Biological Chemistry 270 (45), 27348-27357, 1995 | 1612 | 1995 |
| Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α SJ Leibovich, PJ Polverini, HM Shepard, DM Wiseman, V Shively, ... Nature 329 (6140), 630-632, 1987 | 1572 | 1987 |
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. DJ Good, PJ Polverini, F Rastinejad, MM Le Beau, RS Lemons, ... Proceedings of the National Academy of Sciences 87 (17), 6624-6628, 1990 | 1450 | 1990 |
| Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. NN Nissen, PJ Polverini, AE Koch, MV Volin, RL Gamelli, LA DiPietro The American journal of pathology 152 (6), 1445, 1998 | 1169 | 1998 |
| Activated macrophages induce vascular proliferation PJ Polverini, RS Cotran, MA GIMBRONE JR, ER Unanue Nature 269 (5631), 804-806, 1977 | 1099 | 1977 |
| Engineering tumors with 3D scaffolds C Fischbach, R Chen, T Matsumoto, T Schmelzle, JS Brugge, PJ Polverini, ... Nature methods 4 (10), 855-860, 2007 | 1017 | 2007 |
| Scatter factor induces blood vessel formation in vivo. DS Grant, HK Kleinman, ID Goldberg, MM Bhargava, BJ Nickoloff, ... Proceedings of the National Academy of Sciences 90 (5), 1937-1941, 1993 | 917 | 1993 |
| Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression JE Nör, J Christensen, DJ Mooney, PJ Polverini The American journal of pathology 154 (2), 375-384, 1999 | 879 | 1999 |
| Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 AE Koch, MM Halloran, CJ Haskell, MR Shah, PJ Polverini Nature 376 (6540), 517-519, 1995 | 809 | 1995 |
| Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity SS Tolsma, OV Volpert, DJ Good, WA Frazier, PJ Polverini, N Bouck The Journal of cell biology 122 (2), 497-511, 1993 | 805 | 1993 |
| Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene F Rastinejad, PJ Polverini, NP Bouck Cell 56 (3), 345-355, 1989 | 689 | 1989 |
| Interleukin-8. A corneal factor that induces neovascularization. RM Strieter, SL Kunkel, VM Elner, CL Martonyi, AE Koch, PJ Polverini, ... The American journal of pathology 141 (6), 1279, 1992 | 537 | 1992 |
| Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. DA Arenberg, SL Kunkel, PJ Polverini, M Glass, MD Burdick, RM Strieter The Journal of clinical investigation 97 (12), 2792-2802, 1996 | 520 | 1996 |
| Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. PJ Polverini, SJ Leibovich Laboratory investigation; a journal of technical methods and pathology 51 (6 …, 1984 | 497 | 1984 |
| Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. DR Smith, PJ Polverini, SL Kunkel, MB Orringer, RI Whyte, MD Burdick, ... The Journal of experimental medicine 179 (5), 1409-1415, 1994 | 490 | 1994 |
| Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-α-induced angiogenesis A Pandey, H Shao, RM Marks, PJ Polverini, VM Dixit Science 268 (5210), 567-569, 1995 | 484 | 1995 |
| Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling Q Zeng, S Li, DB Chepeha, TJ Giordano, J Li, H Zhang, PJ Polverini, ... Cancer cell 8 (1), 13-23, 2005 | 455 | 2005 |
| Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. DA Arenberg, SL Kunkel, PJ Polverini, SB Morris, MD Burdick, MC Glass, ... The Journal of experimental medicine 184 (3), 981-992, 1996 | 444 | 1996 |
Robert M. Strieter, M.D.Strieter Consulting在 virginia.edu 的电子邮件经过验证
